AMBS delivers LYMPRO as promised, with further data coming before the end of the quarter. Gerald, and AMBS rebuilding the trust factor in preparation for NASDAQ launch. 2015 is going to be an epic year for AMBS. We've got 5 and a half more trading days in the fourth quarter. Plenty of time for team AMBS to rotate, and lift off. Rubinfeld told us it was coming, so has Gerald. "We Are There"!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links